{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:11:59Z","timestamp":1794039119918,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001516","name":"National Heart Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001516","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Valve replacement surgery is the definitive management strategy for patients with severe valvular disease. However, valvular conduits currently in clinical use are associated with significant limitations. Tissue-engineered (decellularized) heart valves are alternative prostheses that have demonstrated promising early results. The purpose of this systematic review and meta-analysis is to perform robust evaluation of the clinical performance of decellularized heart valves implanted in either outflow tract position, in comparison with standard tissue conduits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Systematic searches were conducted in the PubMed, Scopus, and Web of Science databases for articles in which outcomes between decellularized heart valves surgically implanted within either outflow tract position of human subjects and standard tissue conduits were compared. Primary endpoints included postoperative mortality and reoperation rates. Meta-analysis was performed using a random-effects model via the Mantel-Haenszel method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventeen articles were identified, of which 16 were included in the meta-analysis. In total, 1418 patients underwent outflow tract reconstructions with decellularized heart valves and 2725 patients received standard tissue conduits. Decellularized heart valves were produced from human pulmonary valves and implanted within the right ventricular outflow tract in all cases. Lower postoperative mortality (4.7% vs. 6.1%; RR 0.94, 95% CI: 0.60\u20131.47; <jats:italic>P<\/jats:italic>\u2009=\u20090.77) and reoperation rates (4.8% vs. 7.4%; RR 0.55, 95% CI: 0.36\u20130.84; <jats:italic>P<\/jats:italic>\u2009=\u20090.0057) were observed in patients with decellularized heart valves, although only reoperation rates were statistically significant. There was no statistically significant heterogeneity between the analyzed articles (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u00a0=\u200931%, <jats:italic>P<\/jats:italic>\u2009=\u20090.13 and <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u00a0=\u200933%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.10 respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Decellularized heart valves implanted within the right ventricular outflow tract have demonstrated significantly lower reoperation rates when compared to standard tissue conduits. However, in order to allow for more accurate conclusions about the clinical performance of decellularized heart valves to be made, there need to be more high-quality studies with greater consistency in the reporting of clinical outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-020-01292-y","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T12:06:16Z","timestamp":1600430776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical performance of decellularized heart valves versus standard tissue conduits: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-9423","authenticated-orcid":false,"given":"Steve W. F. R.","family":"Waqanivavalagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus B.","family":"Ground","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paget F.","family":"Milsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"1292_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.athoracsur.2014.10.034","volume":"99","author":"HG Freling","year":"2015","unstructured":"Freling HG, Van Slooten YJ, Van Melle JP, Ebels T, Hoendermis ES, Berger RMF, et al. Pulmonary valve replacement: twenty-six years of experience with mechanical valvar prostheses. Ann Thorac Surg. 2015;99:905\u201310.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"1292_CR2","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/S0735-1097(02)01759-X","volume":"39","author":"JJ Pereira","year":"2002","unstructured":"Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, Stewart WJ, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39(8):1356\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1292_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/01.CIR.66.5.1105","volume":"66","author":"F Schwarz","year":"1982","unstructured":"Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66(5):1105\u201310.","journal-title":"Circulation."},{"key":"1292_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.athoracsur.2012.07.008","volume":"95","author":"HJ Shin","year":"2013","unstructured":"Shin HJ, Kim YH, Ko JK, Park IS, Seo DM. Outcomes of mechanical valves in the pulmonic position in patients with congenital heart disease over a 20-year period. Ann Thorac Surg. 2013;95:1367\u201371.","journal-title":"Ann Thorac Surg"},{"key":"1292_CR5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.athoracsur.2010.07.023","volume":"90","author":"JM Stulak","year":"2010","unstructured":"Stulak JM, Dearani JA, Burkhart HM, Connolly HM, Warnes CA, Suri RM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg. 2010;90:2009\u201314.","journal-title":"Ann Thorac Surg"},{"key":"1292_CR6","first-page":"10","volume":"15","author":"RP Akhtar","year":"2009","unstructured":"Akhtar RP, Abid AR, Zafar H, Khan JS. Aniticoagulation in patients following prosthetic heart valve replacement. Ann Thorac Cardiovasc Surg. 2009;15:10\u20137.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1292_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1378\/chest.127.1.53","volume":"127","author":"D Hering","year":"2005","unstructured":"Hering D, Piper C, Bergemann R, Hillenbach C, Dahm M, Huth C, et al. Thromboembolic and bleeding complications following St. Jude medical valve replacement: results of the German experience with low-intensity anticoagulation study. Chest. 2005;127:53\u20139.","journal-title":"Chest."},{"issue":"4","key":"1292_CR8","doi-asserted-by":"publisher","first-page":"P1113","DOI":"10.1016\/j.athoracsur.2018.05.073","volume":"106","author":"SA Hirji","year":"2018","unstructured":"Hirji SA, Kolkailah AA, Ramirez-Del Val F, Lee J, McGurk S, Pelletier M, et al. Mechanical versus bioprosthetic aortic valve replacement in patients aged 50 years and younger. Ann Thorac Surg. 2018;106(4):P1113\u201320.","journal-title":"Ann Thorac Surg"},{"key":"1292_CR9","first-page":"691","volume":"10","author":"J Butany","year":"2006","unstructured":"Butany J, Soor GS, Chakrabarti M, Vukin I, Leong SW. Prosthetic heart valves, part I: identification and potential complications. Geriatr Aging. 2006;10:691\u20136.","journal-title":"Geriatr Aging"},{"key":"1292_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2559.2008.03190.x","volume":"55","author":"RF Siddiqui","year":"2009","unstructured":"Siddiqui RF, Abraham JR, Butany J. Bioprosthetic heart valves: modes of failure. Histopathology. 2009;55:135\u201344.","journal-title":"Histopathology."},{"issue":"3","key":"1292_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0003-4975(00)01532-0","volume":"70","author":"S Dittrich","year":"2000","unstructured":"Dittrich S, Alexi-Meskishvili VV, Yankah AC, D\u00e4hnert I, Meyer R, Hetzer R, et al. Comparison of porcine xenografts and homografts for pulmonary valve replacement in children. Ann Thorac Surg. 2000;70(3):717\u201322.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"1292_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0033-0620(73)80025-8","volume":"15","author":"WW Angell","year":"1973","unstructured":"Angell WW, DeLanerolle P, Shumway NE. Valve replacement: present status of homograft valves. Prog Cardiovasc Dis. 1973;15(6):589\u2013622.","journal-title":"Prog Cardiovasc Dis"},{"issue":"33","key":"1292_CR13","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1016\/j.biomaterials.2006.06.020","volume":"27","author":"E Rieder","year":"2006","unstructured":"Rieder E, Nigisch A, Dekan B, Kasimir MT, M\u00fchlbacher F, Wolner E, et al. Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue. Biomaterials. 2006;27(33):5634\u201342.","journal-title":"Biomaterials."},{"key":"1292_CR14","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1161\/CIRCULATIONAHA.104.473629","volume":"111","author":"E Rieder","year":"2005","unstructured":"Rieder E, Seebacher G, Kasimir MT, Eichmair E, Winter B, Dekan B, et al. Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation. 2005;111:2792\u20137.","journal-title":"Circulation."},{"issue":"2","key":"1292_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.matbio.2004.03.005","volume":"23","author":"K Schenke-Layland","year":"2004","unstructured":"Schenke-Layland K, Riemann I, Opitz F, K\u00f6nig K, Halbhuber KJ, Stock UA. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol. 2004;23(2):113\u201325.","journal-title":"Matrix Biol"},{"issue":"19 Suppl 3","key":"1292_CR16","first-page":"III50","volume":"102","author":"G Steinhoff","year":"2000","unstructured":"Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation. 2000;102(19 Suppl 3):III50\u20135.","journal-title":"Circulation."},{"issue":"2","key":"1292_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jtcvs.2003.06.017","volume":"127","author":"E Rieder","year":"2004","unstructured":"Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, Simon P, et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg. 2004;127(2):399\u2013405.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"15\u201316","key":"1292_CR18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1089\/ten.tea.2012.0074","volume":"19","author":"I Tudorache","year":"2013","unstructured":"Tudorache I, Calistru A, Baraki H, Meyer T, H\u00f6ffler K, Sarikouch S, et al. Orthotopic replacement of aortic heart valves with tissue-engineered grafts. Tissue Eng Part A. 2013;19(15\u201316):1686\u201394.","journal-title":"Tissue Eng Part A"},{"issue":"4","key":"1292_CR19","first-page":"225","volume":"4","author":"PM Dohmen","year":"2012","unstructured":"Dohmen PM. Clinical results of implanted tissue engineered heart valves. HSR Proc Intensive Care Cardiovasc Anesth. 2012;4(4):225\u201331.","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"issue":"3","key":"1292_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jsb.2003.08.002","volume":"143","author":"K Schenke-Layland","year":"2003","unstructured":"Schenke-Layland K, Vasilevski O, Opitz F, K\u00f6nig K, Riemann I, Halbhuber KJ, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol. 2003;143(3):201\u20138.","journal-title":"J Struct Biol"},{"issue":"3","key":"1292_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.athoracsur.2007.04.072","volume":"84","author":"PM Dohmen","year":"2007","unstructured":"Dohmen PM, Lembcke A, Holinski S, Kivelitz D, Braun JP, Pruss A, et al. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg. 2007;84(3):729\u201336.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"1292_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10047-006-0360-1","volume":"10","author":"S Iwai","year":"2007","unstructured":"Iwai S, Torikai K, Coppin CM, Sawa Y. Minimally immunogenic decellularized porcine valve provides in situ recellularization as a stentless bioprosthetic valve. J Artif Organs. 2007;10(1):29\u201335.","journal-title":"J Artif Organs"},{"issue":"2","key":"1292_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jbm.b.33552","volume":"105","author":"GL Converse","year":"2017","unstructured":"Converse GL, Buse EE, Neill KR, McFall CR, Lewis HN, VeDepo MC, et al. Design and efficacy of a single-use bioreactor for heart valve tissue engineering. J Biomed Mater Res - Part B Appl Biomater. 2017;105(2):249\u201359.","journal-title":"J Biomed Mater Res - Part B Appl Biomater"},{"key":"1292_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s13239-018-00382-2","volume":"10","author":"BJ Tefft","year":"2019","unstructured":"Tefft BJ, Choe JA, Young MD, Hennessy RS, Morse DW, Bouchard JA, et al. Cardiac valve bioreactor for physiological conditioning and hydrodynamic performance assessment. Cardiovasc Eng Technol. 2019;10:80\u201394.","journal-title":"Cardiovasc Eng Technol"},{"issue":"6","key":"1292_CR25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1010-7940(03)00094-0","volume":"23","author":"P Simon","year":"2003","unstructured":"Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT\u2122 in pediatric patients. Eur J Cardio-thoracic Surg. 2003;23(6):1002\u20136.","journal-title":"Eur J Cardio-thoracic Surg."},{"issue":"1","key":"1292_CR26","first-page":"78","volume":"14","author":"W Konertz","year":"2005","unstructured":"Konertz W, Dohmen PM, Liu J, Beholz S, Dushe S, Posner S, et al. Hemodynamic characteristics of the matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis. 2005;14(1):78\u201381.","journal-title":"J Heart Valve Dis"},{"key":"1292_CR27","unstructured":"Konertz W, Dohmen P. Method for decellularising foreign material for the production of bioprostheses 2004;1(19):12\u201317. Available from: https:\/\/patentimages.storage.googleapis.com\/63\/50\/48\/aac2bdc35e50ce\/CA2428880C.pdf."},{"key":"1292_CR28","unstructured":"Bolland F, Southgate J, Korossis S, Ingham E. Decellularisation of tissue matrices for bladder implantation. 2015;2(12). Available from: https:\/\/patentimages.storage.googleapis.com\/59\/4a\/27\/acc29a59d8b0c5\/US9180144.pdf."},{"key":"1292_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000091597","volume":"38","author":"PM Dohmen","year":"2006","unstructured":"Dohmen PM, Da Costa F, Holinski S, Lopes SV, Yoshi S, Reichert LH, et al. Is there a possibility for a glutaraldehyde-free porcine heart valve to grow? Eur Surg Res. 2006;38:54\u201361.","journal-title":"Eur Surg Res"},{"issue":"1","key":"1292_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13019-017-0621-5","volume":"12","author":"MRK Helder","year":"2017","unstructured":"Helder MRK, Stoyles NJ, Tefft BJ, Hennessy RS, Hennessy RRC, Dyer R, et al. Xenoantigenicity of porcine decellularized valves. J Cardiothorac Surg. 2017;12(1):56.","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"1292_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/icvts\/ivx131","volume":"25","author":"CS Park","year":"2017","unstructured":"Park CS, Kim YJ, Lee JR, Lim HG, Chang JE, Jeong S, et al. Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model. Interact Cardiovasc Thorac Surg. 2017;25(3):391\u20139.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1 Suppl","key":"1292_CR32","first-page":"I132","volume":"114","author":"S Cebotari","year":"2006","unstructured":"Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation. 2006;114(1 Suppl):I132\u20137.","journal-title":"Circulation"},{"issue":"4","key":"1292_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1590\/S0102-76382007000400012","volume":"22","author":"F Costa","year":"2007","unstructured":"Costa F, Dohmen P, Vieira E, Pereira EWL, Matsuda CN, Lopes SV, et al. Ross operation with decelularized pulmonary allografts: medium-term results. Brazilian J Cardiovasc Surg. 2007;22(4):454\u201362.","journal-title":"Brazilian J Cardiovasc Surg"},{"issue":"2","key":"1292_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/ejcts\/ezw050","volume":"50","author":"S Sarikouch","year":"2016","unstructured":"Sarikouch S, Horke A, Tudorache I, Beerbaum P, Westhoff-Bleck M, Boethig D, et al. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardio-thoracic Surg. 2016;50(2):281\u201390.","journal-title":"Eur J Cardio-thoracic Surg."},{"issue":"7","key":"1292_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"1292_CR36","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2000 [cited 2020 Apr 23]. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/nosgen.pdf."},{"key":"1292_CR37","first-page":"1","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:1\u20137.","journal-title":"BMJ."},{"key":"1292_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557\u201360.","journal-title":"Br Med J"},{"issue":"3","key":"1292_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ejcts.2004.12.017","volume":"27","author":"JFM Bechtel","year":"2005","unstructured":"Bechtel JFM, Erasmi AW, Petersen M, Stierle U, Sievers H-H, Gellissen J, et al. Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts. Eur J Cardio-thoracic Surg. 2005;27(3):410\u20135.","journal-title":"Eur J Cardio-thoracic Surg."},{"issue":"1","key":"1292_CR40","first-page":"98","volume":"17","author":"M Bechtel","year":"2008","unstructured":"Bechtel M, Stierle U, Sievers H-H. Fifty-two months\u2019 mean follow up of decellularized SynerGraft\u2122- treated pulmonary valve allografts. J Heart Valve Dis. 2008;17(1):98\u2013104.","journal-title":"J Heart Valve Dis."},{"issue":"3","key":"1292_CR41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.athoracsur.2016.07.068","volume":"103","author":"S Bibevski","year":"2017","unstructured":"Bibevski S, Ruzmetov M, Fortuna RS, Turrentine MW, Brown JW, Ohye RG. Performance of SynerGraft Decellularized pulmonary allografts compared with standard cryopreserved allografts: results from multiinstitutional data. Ann Thorac Surg. 2017;103(3):869\u201374.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"1292_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/ejcts\/ezz054","volume":"56","author":"D Boethig","year":"2019","unstructured":"Boethig D, Horke A, Hazekamp M, Meyns B, Rega F, Van Puyvelde J, et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR trial and ESPOIR registry data\u2020. Eur J Cardio-Thoracic Surg. 2019;56(3):503\u20139.","journal-title":"Eur J Cardio-Thoracic Surg"},{"issue":"2","key":"1292_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jtcvs.2009.04.065","volume":"139","author":"JW Brown","year":"2010","unstructured":"Brown JW, Elkins RC, Clarke DR, Tweddell JS, Huddleston CB, Doty JR, et al. Performance of the CryoValve* SG human decellularized pulmonary valve in 342 patients relative to the conventional CryoValve at a mean follow-up of four years. J Thorac Cardiovasc Surg. 2010;139(2):339\u201348 Available from: https:\/\/doi.org\/10.1016\/j.jtcvs.2009.04.065.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"1292_CR44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.athoracsur.2010.10.069","volume":"91","author":"JW Brown","year":"2011","unstructured":"Brown JW, Ruzmetov M, Eltayeb O, Rodefeld MD, Turrentine MW. Performance of SynerGraft decellularized pulmonary homograft in patients undergoing a Ross procedure. Ann Thorac Surg. 2011;91(2):416\u201323.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"1292_CR45","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.athoracsur.2010.05.024","volume":"90","author":"PT Burch","year":"2010","unstructured":"Burch PT, Kaza AK, Lambert LM, Holubkov R, Shaddy RE, Hawkins JA. Clinical performance of decellularized cryopreserved valved allografts compared with standard allografts in the right ventricular outflow tract. Ann Thorac Surg. 2010;90(4):1301\u20136.","journal-title":"Ann Thorac Surg"},{"key":"1292_CR46","doi-asserted-by":"crossref","unstructured":"Cebotari S, Tudorache I, Ciubotaru A, Boethig D, Sarikouch S, Goerler A, et al. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: Early report. Circulation. 2011;124(11 SUPPL. 1):115\u201323.","DOI":"10.1161\/CIRCULATIONAHA.110.012161"},{"issue":"4","key":"1292_CR47","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ejcts.2004.12.057","volume":"27","author":"FD Affonso Da Costa","year":"2005","unstructured":"Affonso Da Costa FD, Dohmen PM, Duarte D, Von Glenn C, Lopes SV, Haggi Filho H, et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. Eur J Cardio-thoracic Surg. 2005;27(4):572\u20138.","journal-title":"Eur J Cardio-thoracic Surg."},{"key":"1292_CR48","doi-asserted-by":"publisher","unstructured":"da Costa FDA, Etnel JRG, Charitos EI, Sievers HH, Stierle U, Fornazari D, et al. Decellularized versus standard pulmonary allografts in the Ross procedure: propensity-matched analysis. Ann Thorac Surg. 2018;105(4):1205\u201313. Available from: https:\/\/doi.org\/10.1016\/j.athoracsur.2017.09.057.","DOI":"10.1016\/j.athoracsur.2017.09.057"},{"issue":"3","key":"1292_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ejcts\/ezy079","volume":"54","author":"JRG Etnel","year":"2018","unstructured":"Etnel JRG, Suss PH, Schnorr GM, Veloso M, Colatusso DF, Filho EMB, et al. Fresh decellularized versus standard cryopreserved pulmonary allografts for right ventricular outflow tract reconstruction during the Ross procedure: a propensity-matched study. Eur J Cardio-Thoracic Surg. 2018;54(3):434\u201340.","journal-title":"Eur J Cardio-Thoracic Surg."},{"issue":"3","key":"1292_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.athoracsur.2009.06.003","volume":"88","author":"T Konuma","year":"2009","unstructured":"Konuma T, Devaney EJ, Bove EL, Gelehrter S, Hirsch JC, Tavakkol Z, et al. Performance of CryoValve SG Decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg. 2009;88(3):849\u201355 Available from: https:\/\/doi.org\/10.1016\/j.athoracsur.2009.06.003.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"1292_CR51","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jtcvs.2011.12.032","volume":"143","author":"M Ruzmetov","year":"2012","unstructured":"Ruzmetov M, Shah JJ, Geiss DM, Fortuna RS. Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: a single-institution comparison. J Thorac Cardiovasc Surg [Internet]. 2012;143(3):543\u20139 Available from: https:\/\/doi.org\/10.1016\/j.jtcvs.2011.12.032.","journal-title":"J Thorac Cardiovasc Surg [Internet]"},{"issue":"1","key":"1292_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00392-003-0883-x","volume":"92","author":"HH Sievers","year":"2003","unstructured":"Sievers HH, Stierl U, Schmidtke C, Bechtel M. Decellularized pulmonary homograft (SynerGraft) for reconstruction of the right ventricular outflow tract: first clinical experience. Z Kardiol. 2003;92(1):53\u20139.","journal-title":"Z Kardiol"},{"issue":"5","key":"1292_CR53","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.athoracsur.2005.04.017","volume":"80","author":"Z Tavakkol","year":"2005","unstructured":"Tavakkol Z, Gelehrter S, Goldberg CS, Bove EL, Devaney EJ, Ohye RG. Superior durability of synergraft pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg. 2005;80(5):1610\u20134.","journal-title":"Ann Thorac Surg"},{"issue":"4 Suppl 1","key":"1292_CR54","first-page":"194","volume":"11","author":"MF O\u2019Brien","year":"1999","unstructured":"O\u2019Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg. 1999;11(4 Suppl 1):194\u2013200.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"1292_CR55","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1161\/01.HYP.0000070029.30058.59","volume":"41","author":"F Antonini-Canterin","year":"2003","unstructured":"Antonini-Canterin F, Huang G, Cervesato E, Faggiano P, Pavan D, Piazza R, et al. Symptomatic aortic stenosis: does systemic hypertension play an additional role? Hypertension. 2003;41(6):1268\u201372.","journal-title":"Hypertension."},{"key":"1292_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/CIRCULATIONAHA.116.022800","volume":"134","author":"A Mazine","year":"2016","unstructured":"Mazine A, David TE, Rao V, Hickey EJ, Christie S, Manlhiot C, et al. Long-term outcomes of the ross procedure versus mechanical aortic valve replacement. Circulation. 2016;134:576\u201385.","journal-title":"Circulation."},{"issue":"6","key":"1292_CR57","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0003-4975(00)01812-9","volume":"70","author":"S Goldstein","year":"2000","unstructured":"Goldstein S, Clarke DR, Walsh SP, Black KS, O\u2019brien MF. Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg. 2000;70(6):1962\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"1292_CR58","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1093\/ejcts\/ezt328","volume":"44","author":"I Voges","year":"2013","unstructured":"Voges I, Br\u00e4sen JH, Entenmann A, Scheid M, Scheewe J, Fischer G, et al. Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imaging. Eur J Cardio-thoracic Surg. 2013;44(4):e272\u20139.","journal-title":"Eur J Cardio-thoracic Surg"},{"issue":"5","key":"1292_CR59","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/ejcts\/ezy377","volume":"55","author":"T Christ","year":"2019","unstructured":"Christ T, Paun AC, Grubitzsch H, Holinski S, Falk V, Dushe S. Long-term results after the Ross procedure with the decellularized AutoTissue matrix P\u00ae bioprosthesis used for pulmonary valve replacement. Eur J Cardio-Thoracic Surg. 2019;55(5):885\u201392.","journal-title":"Eur J Cardio-Thoracic Surg."},{"key":"1292_CR60","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/ejcts\/ezr221","volume":"41","author":"G Perri","year":"2012","unstructured":"Perri G, Polito A, Esposito C, Albanese SB, Francalanci P, Pongiglione G, et al. Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. Eur J Cardio-Thoracic Surg. 2012;41:1320\u20135.","journal-title":"Eur J Cardio-Thoracic Surg."},{"key":"1292_CR61","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejcts.2010.01.044","volume":"38","author":"A R\u00fcffer","year":"2010","unstructured":"R\u00fcffer A, Purbojo A, Cicha I, Gl\u00f6ckler M, Potapov S, Dittrich S, et al. Early failure of xenogenous de-cellularised pulmonary valve conduits - a word of caution! Eur J Cardio-Thoracic Surg. 2010;38:78\u201385.","journal-title":"Eur J Cardio-Thoracic Surg."}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-020-01292-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T23:28:50Z","timestamp":1631921330000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-020-01292-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1186\/s13019-020-01292-y","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}